Stein, Kenneth (19..-....)

Date de naissance
19XX
Langues d'expression
anglais
Cardiologue. Professeur associé de médecine à la Cornell University (2012)

STEIN Kenneth, Boston Scientific, USA<br>Kenneth Stein, MD, FACC, FHRS, Senior Vice President & Chief Medical Officer Cardiac Rhythm Management. Ken Stein, MD, FACC, FHRS, is currently Chief Medical Officer and Senior Vice President for Boston Scientific’s Cardiac Rhythm Management (CRM) division of the Cardiology, Rhythm and Vascular (CRV) Group.
Dr. Stein held the position of Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University prior to joining Boston Scientific in September of 2009.
Dr. Stein currently oversees the development and execution of clinical strategy for the Company’s CRM division. Ken is a Phi Beta Kappa graduate of Harvard College
(magna cum laude in Economics), and he earned his MD from New York University School of Medicine. He completed his medical internship and residency at The
New York-Presbyterian Hospital/Weill Cornell Medical Center, where he also completed his cardiology and electrophysiology training. He has published widely in the areas of cardiac electrophysiology with special interest in cardiac resynchronization therapy and risk stratification for sudden cardiac arrest.

Vidéos

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Comparative effectiveness studies (Kenneth STEIN)
Conférence
00:21:52

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 1 : Comparative effecti…

Stein
Kenneth

MODIGLIANI Lunch Debate Session 1 - Friday November 30, 2012 THE DEVICE THERAPY TRIALISTS WORKSHOP Chairpersons: Gaetano DE FERRARI, Pavia, ITA - Ileana PIÑA, New York, USA Webcast: Tariq AHMAD,

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in autonomic nerve modulation therapy trials? What kind/level of evidence? Targets to meet for approval (FDA, and in EU, beyond CE mark) and reimbursement
Conférence
00:04:13

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in a…

Stein
Kenneth

Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate : What relevant endpoints in autonomic nerve modulation therapy trials? What kind/level of evidence? Targets to meet for